As would be expected in a short duration study, there was no change in disability caused by
multiple sclerosis as assessed by the Expanded
Disability Status Score. The study found that stable blood levels of LA required a dose of 1,200 mg, and treatment was associated with changes in serum immunologic markers associated with T-cell migration into the CNS.